TGF-β has been shown to activate the downstream gene Smad3, which inhibits the expression of PPARγ coactivator-1α (PGC-1α) gene, potentially leading to mild obesity in individuals with reduced CCN5 expression [22]. The gene discussed is CCN5; the disease is Obesity.